HRID 52177als Produkt
154355-75-6C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=OMMSNEKOTSJRTRI-LLVKDONJSA-NAtreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.
154355-75-6、154355-76-7DTXSID10165598Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
VerwendenAnti-asthmatic; inhibitor (5-lipoxygenase).
CHEMBL59356